Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation

Abstract Objective: To characterize the clinical features of women with singleton pregnancies who develop proteinuria in the absence of hypertension after mid-gestation. Methods: Seventy-nine women who developed proteinuria and/or hypertension at and after 20 weeks of gestation were reviewed, focusing on the gestational week at which significant proteinuria (>0.3 g/day) and/or hypertension developed. Results: Thirty-seven (47%) women exhibited new-onset proteinuria (>0.3 g/day) in the absence of hypertension, 33 (42%) exhibited new-onset hypertension in the absence of proteinuria, and 9 (11%) exhibited both proteinuria and hypertension. Nineteen (51%) of 37 women who exhibited new proteinuria in the absence of hypertension and 5 (15%) of 33 women who exhibited new hypertension in the absence of proteinuria progressed to preeclampsia (P=0.002). Among women who exhibited new proteinuria, 10 (77%) out of 13 women and 9 (38%) out of 24 women who developed proteinuria at <32 weeks and ≥32 weeks, respectively, progressed to preeclampsia (P=0.022). Conclusions: Women with new-onset proteinuria in the absence of hypertension may be more likely to progress to preeclampsia than women with a presumptive diagnosis of gestational hypertension, and the likelihood of progression may be significantly greater among women with earlier presentation.

[1]  R. Ness,et al.  Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.

[2]  M. Özeren,et al.  Coagulation inhibitors in preeclamptic pregnant women , 2005, Archives of Gynecology and Obstetrics.

[3]  Shigenori Suzuki,et al.  Gestational thrombocytopenia and pregnancy-induced antithrombin deficiency: progenitors to the development of the HELLP syndrome and acute fatty liver of pregnancy. , 2002, Seminars in thrombosis and hemostasis.

[4]  U. Hanson,et al.  ECLAMPSIA IN SWEDEN , 2002, Hypertension in pregnancy.

[5]  B. Sibai,et al.  Mild gestational hypertension remote from term: progression and outcome. , 2001, American journal of obstetrics and gynecology.

[6]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[7]  J. Higgins,et al.  The detection, investigation and management of hypertension in pregnancy: full consensus statement , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

[8]  S. Matsubara,et al.  Association of a decrease in antithrombin III activity with a perinatal elevation in aspartate aminotransferase in women with twin pregnancies: relevance to the HELLP syndrome. , 1999, Journal of hepatology.

[9]  M. Brown,et al.  Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.

[10]  S. Matsubara,et al.  Relation between Gestational Thrombocytopenia and the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP Syndrome) , 1998, Gynecologic and Obstetric Investigation.

[11]  M. Mussap,et al.  Coagulation and plasma fibronectin parameters in HELLP syndrome , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  C. Redman,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[13]  A. Berrebi,et al.  Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre‐eclampsia , 1993, British journal of obstetrics and gynaecology.

[14]  C. Ho,et al.  The Predictive Value of the Hemostasis Parameters in the Development of Preeclampsia , 1992, Thrombosis and Haemostasis.

[15]  A. Caruso,et al.  Proteinuria and outcome of 444 pregnancies complicated by hypertension. , 1990, American journal of obstetrics and gynecology.

[16]  J. T. ten Cate,et al.  Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. , 1984, American journal of obstetrics and gynecology.

[17]  T. Goodwin,et al.  Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. , 1996, American journal of obstetrics and gynecology.

[18]  L. Chesley Diagnosis of preeclampsia. , 1985, Obstetrics and gynecology.

[19]  J. T. ten Cate,et al.  Plasma antithrombin III levels in pre-eclampsia. , 1983, Clinical and experimental hypertension. Part B, Hypertension in pregnancy.